Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2006
03/08/2006CN1244681C Humicole uspergillus
03/08/2006CN1244595C Tumor suppressor protein and its application
03/08/2006CN1244521C Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
03/08/2006CN1244403C Chromatography material and method using same
03/08/2006CN1244269C Method for large-scale inducing plant gene mutation
03/07/2006USRE39007 Isothermal strand displacement nucleic acid amplification
03/07/2006US7010430 Method for displaying gene experiment data
03/07/2006US7009093 produced by crossing the inbred maize line PH183 with another maize plant; resistance to diseases and insects, tolerance to heat and drought, reducing the time to crop maturity, greater yield, and better agronomic quality
03/07/2006US7009092 Transgenic corn plants having seeds with modified cornstarch characteristics and method of making the transgenic corn plants
03/07/2006US7009091 hybrid cotton seeds and plants produced by crossing the cultivar DP 560 BGII with itself or another cotton cultivar; insect resistance, disease resistance, herbicide resistance
03/07/2006US7009090 plant transformed polynucleotide molecule comprising nucleotide sequence encoding insect virus fusolin protein or fusolin-like protein operably linked to suitable promoter sequence, where plant expresses fusolin protein in damage susceptible tissue
03/07/2006US7009089 Genes encoding sterol delta-14 reductase in plants
03/07/2006US7009088 Methods of modulating auxin production in plants
03/07/2006US7009087 nucleotide molecules comprising sequences for thioredoxin h and NADPH-thioredoxin reductase; can be used to transform plants alone or in combination with other sequences to manipulate thioredoxin h system and alter protein disulfide status
03/07/2006US7009045 Nucleotide sequences coding polypeptide for use in the biosynthesis of riboflavin
03/07/2006US7009044 hepatitis c virus (HCV); bovine viral diarrhea virus (BVDV); for production of virions for use in antibody neutralization assays; vaccines
03/07/2006US7009043 isolated from xenopus egg extracts; adenosine triphosphatases; mitosis
03/07/2006US7009035 Peptide for use in the diagnosis and treatment of tumors
03/07/2006US7008925 use for treatment of medical and veterinary conditions which can be influenced by the MC1-receptor; act as immunomodulators and to affect motivation, learning, memory, behaviour, inflammation, body temperature, pain, perception
03/07/2006US7008921 Materials and methods relating to endothelial cell growth inhibitors
03/07/2006US7008791 Liposome-entrapped DNA oral vaccines
03/07/2006US7008787 Apparatus for use in transformation of cells
03/07/2006US7008783 Nucleic acid sequences coding for chondroitinase ABC gene and isolated chondroitinase ABC protein produced in a host cell transformed with a nucleic acid vector directing the expression of a nucleotide sequence coding for chondroitinase ABC
03/07/2006US7008782 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of preferential genetic disorder
03/07/2006US7008781 Method of enhancing the biological activity of ligands
03/07/2006US7008780 Chimeric DNA-binding proteins
03/07/2006US7008779 novel gene and protein designated PHELIX; in normal individuals, expressed only in testis, but expressed at high levels in advanced and metastatic prostate cancer, and expressed at lower levels in testicular, bladder, ovarian cancers
03/07/2006US7008778 Breast cancer specific gene 1
03/07/2006US7008770 Method for the controlled implementation of complex PCR amplifications
03/07/2006US7008767 Cloning preferential genes; obtain cells, transform, express preferential genes in cells, monitor activity of genes in biosynthetic process
03/07/2006US7008766 determining the sequence of a polynucleotide, by reacting target polynucleotides with polymerases immobilised on solid supports, then detecting incorporation of specific nucleotide complementarity using surface plasmon resonance spectrum analysis
03/07/2006US7008765 polynucleotides that code for prostate specific antigen proteins or polypeptides; cells containing the recombinant nucleic acid molecules; hybridomas containing the antibodies; kits containing probes or antibodies; prevention of prostate cancer
03/07/2006US7008764 Optimization of cells for endogenous gene activation
03/07/2006US7008664 Method for improving the carcass quality of an animal
03/07/2006US7008625 Recombinant constructs of Borrelia burgdorferi
03/07/2006US7008623 Antibodies to CD23, derivatives thereof, and their therapeutic uses
03/07/2006US7008622 Methods and compositions for impairing multiplication of HIV-1
03/02/2006WO2006024041A2 Monomeric and dimeric fluorescent protein variants and methods for making same
03/02/2006WO2006023956A2 Method for gene transfer into the organelles of cells: direct gene transfer to mitochondria
03/02/2006WO2006023848A2 Rna interference vectors
03/02/2006WO2006023766A2 P450 polynucleotides, polypeptides, and uses thereof
03/02/2006WO2006023560A2 Eukaryotic translation initiation factor gene regulatory elements for use in plants
03/02/2006WO2006023546A2 Process for plasmid dna fermentation
03/02/2006WO2006023544A2 Therapeutic uses of inhibitors of rtp801
03/02/2006WO2006023495A2 Carotenoid hydroxylase enzymes
03/02/2006WO2006023491A2 Method of delivering rna interference and uses thereof
03/02/2006WO2006023471A2 Additive, method, and article for dna collection, stabilization, and purification
03/02/2006WO2006023210A2 Gp132: mehods and compositions for treating cancer
03/02/2006WO2006023144A2 Look-through mutagenesis for developing altered polypeptides with enhanced properties
03/02/2006WO2006022958A1 Method and apparatus for substantially isolating plant tissues
03/02/2006WO2006022947A1 Protein and nucleic acid sequence encoding a krill-derived cold adapted trypsin-like activity enzyme
03/02/2006WO2006022944A2 Lentiviral vectors and uses thereof
03/02/2006WO2006022887A1 Nanocoating for improving biocompatibility of medical implants
03/02/2006WO2006022712A1 Methods and agents for screening for compounds capable of modulating gene expression
03/02/2006WO2006022457A1 Synoviolin transgenic flies
03/02/2006WO2006022422A1 Modified human hepatitis c virus genomic rna having autonomous replicative competence
03/02/2006WO2006022361A1 Psf1 GENE-DEFICIENT ANIMAL AND METHOD OF USING THE SAME
03/02/2006WO2006022344A1 Utilization of anti-mortalin 2 antibody and functional nucleic acid in treating cancer
03/02/2006WO2006022343A1 Gonadotropic hormone originating in invertebrate and method of producing the same
03/02/2006WO2006022330A1 Method of producing dendritic cell from prrimate embryonic stem cell
03/02/2006WO2006022249A1 Target nucleic acid of retrovirus integration
03/02/2006WO2006022239A1 Sequence of themotolerant l-rhamnose isomerase gene and use of the same
03/02/2006WO2006022215A1 RECOMBINANT VACCINICA VIRUS DIs STRAIN HOLDING DNA ENCODING SARS-CORONAVIRUS PROTEIN AND UTILIZATION THEREOF
03/02/2006WO2006021972A1 A novel cytoplasmic male sterility system for brassica species and its use for hybrid seed production in indian oilseed mustard brassica juncea
03/02/2006WO2006021874A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer
03/02/2006WO2006021817A2 Treatment of eye disorders characterized by an elevated introacular pressure by sirnas
03/02/2006WO2006021800A2 Tumour model
03/02/2006WO2006021724A2 Adeno-associated viral vector for exon skipping in a gene encoding a dispensable-domain protein
03/02/2006WO2006021558A2 A plant with reduced lignin by modulating dahps gene expression
03/02/2006WO2006021453A2 Optimized nucleotide sequences encoding sgp 130
03/02/2006WO2006021210A2 Binding member towards pneumolysin
03/02/2006WO2006021062A1 Process for obtaining recombinant prothrombin activating protease (rlopap) in monomeric form; the recombinant prothrombin activating protease (rlopap) as well as its amino acid sequence; the use of this protease as a defibrinogenase agent and the diagnosis kit for dysprothrombinemias.
03/02/2006WO2006012080A3 Microbial glyphosate resistant 5-enolpyruvylshikimate-3-phosphate synthases
03/02/2006WO2006011815A3 Phosphatases, polynucleotides encoding these and uses thereof
03/02/2006WO2006002193A3 Prrsv subunit vaccines
03/02/2006WO2006000448A3 Fc-INTERFERON-BETA FUSION PROTEINS
03/02/2006WO2005121172A3 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
03/02/2006WO2005113590A3 Bmp10 propeptides and related methods
03/02/2006WO2005110492A3 Method of using adenoviral vectors to induce an immune response
03/02/2006WO2005105136A9 Nanogene therapy for cell proliferation disorders
03/02/2006WO2005095988A3 Selection of bacterial inner-membrane anchor polypeptides
03/02/2006WO2005095618A3 Plants with reduced activity of the starch phosphorylating enzyme phosphoglucan, water dikinase
03/02/2006WO2005095617A3 Plants with increased activity of a starch phosphorylating enzyme
03/02/2006WO2005089735A3 Compositions and methods for treating lung cancer
03/02/2006WO2005089093A3 Improved expression systems with sec-system secretion
03/02/2006WO2005087932A3 Vectors for directional cloning
03/02/2006WO2005087802A3 Process for producing polypeptides
03/02/2006WO2005084714A3 Raav-neprilysin compositions and methods of use
03/02/2006WO2005072088A3 Immunotherapy compositions, method of making and method of use thereof
03/02/2006WO2005071414A3 Kit for immobilizing organic substance, organic substance-immobilized structure, and manufacturing methods therefor
03/02/2006WO2005070214A3 Peptides for inhibiting insects
03/02/2006WO2005059093A3 P ef-tu expression units
03/02/2006WO2005053600A3 Antisense compounds targeted to connexins and methods of use thereof
03/02/2006WO2005049630A3 Antisense modulation of kinesin-like 1 expression
03/02/2006WO2005045038A3 RNA interference mediated inhibition of GPRA and AAA1 gene expression using short nucleic acid (siNA)
03/02/2006WO2005045036A3 Rna interference mediated inhibition of hairless (hr) gene expression using short interfering nucleic acid (sina)
03/02/2006WO2005045032A3 RNA INTERFERENCE MEDIATED INHIBITION OF EARLY GROWTH RESPONSE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
03/02/2006WO2005040379A3 RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
03/02/2006WO2005037993A3 Promoters functional in plant plastids
03/02/2006WO2005032487A3 Angiotensin-converting enzyme-2 as a receptor for the sars coronavirus